Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 1, Pages 422-435
Publisher
Wiley
Online
2017-09-08
DOI
10.1002/hep.29486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib
- (2016) Manuel A. de la Torre et al. LIVER INTERNATIONAL
- Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
- (2016) Young Youn Cho et al. PLoS One
- Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection
- (2016) Bingnan Zhang et al. Liver Cancer
- Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis
- (2015) Julien Edeline et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
- (2015) Gi-Ae Kim et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
- (2015) Y. Zhang et al. ONCOLOGIST
- Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study
- (2014) Xuefen Tan et al. Asia-Pacific Journal of Clinical Oncology
- Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
- (2014) Takahide Nakazawa et al. BMC GASTROENTEROLOGY
- How to Read a Systematic Review and Meta-analysis and Apply the Results to Patient Care
- (2014) Mohammad Hassan Murad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
- (2014) Do Seon Song et al. JOURNAL OF GASTROENTEROLOGY
- Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma
- (2014) Julien Edeline et al. Liver Cancer
- Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability
- (2013) Eileen L. Yoon et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cryotherapy is Associated with Improved Clinical Outcomes of Sorafenib Therapy for Advanced Hepatocellular Carcinoma
- (2012) Yongping Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma
- (2010) Brian I. Carr et al. CANCER
- Loco-regional treatment of hepatocellular carcinoma
- (2010) Riccardo Lencioni HEPATOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer
- (2009) L. Marelli et al. JOURNAL OF NUCLEAR MEDICINE
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started